© 2008

Myeloma Therapy

Pursuing the Plasma Cell

  • Sagar Lonial

Part of the Contemporary Hematology book series (CH)

Table of contents

  1. Front Matter
    Pages i-xvi
  2. Biologic Consideration and Myeloma

    1. Leonard T. Heffner
      Pages 3-7
    2. Amelia A. Langston, Dixil Francis
      Pages 9-22
    3. Wee Joo Chng, Peter Leif Bergsagel
      Pages 41-56
    4. Esteban Braggio, Michael Sebag, Rafael Fonseca
      Pages 57-76
  3. Historical and Cytotoxic Agent-Based Therapies for Myeloma

    1. Jonathan L. Kaufman, Ronald Mihelic, Sagar Lonial
      Pages 91-98
    2. Bringhen Sara, Palumbo Antonio
      Pages 99-112
    3. Sikander Ailawadhi, Asher Chanan-Khan
      Pages 113-121
  4. Immune-Based Therapies

    1. Fengrong Wang, Edmund K. Waller
      Pages 125-142
    2. Madhav V. Dhodapkar
      Pages 143-166
    3. Nikhil C. Munshi, Yu-Tzu Tai
      Pages 167-202
  5. Existing Novel Agents

    1. Francis K. Buadi, S. Vincent Rajkumar
      Pages 229-237
    2. Paul G. Richardson, Constantine S. Mitsiades, Robert Schlossman, Teru Hideshima, Irene Ghobrial, Nikhil C. Munshi et al.
      Pages 239-252
    3. San J. F. Miguel, M. V. Mateos
      Pages 253-263
    4. Sheeba K. Thomas, Tiffany A. Richards, Donna M. Weber
      Pages 265-277
  6. Current and Future Targets

    1. Constantine S. Mitsiades, Teru Hideshima, Nikhil C. Munshi, Paul G. Richardson, Kenneth C. Anderson
      Pages 291-308

About this book


Therapeutic options for patients with myeloma have radically changed over the past ten years. Myeloma Therapy: Pursuing the Plasma Cell provides updated various treatment options for patients with myeloma, with focus on the emerging and speculative aspects of myeloma therapy. Written by clearly acknowledged leaders in the field of myeloma therapy and research, Myeloma Therapy: Pursuing the Plasma Cell presents significant material on the biology and potential agents used to address specific signaling pathways, all of which are critical to myeloma biology and therapy. State of the art information from many of the leaders in the plasma cell disorders world includes disease pathogenesis and biology, chemotherapy based approaches, immune based therapies, currently approved novel agents, developing targets, supportive care, and other plasma cell disorders. Myeloma Therapy: Pursuing the Plasma Cell is a comprehensive collection and tremendous source in this time of rapid change in clinical and preclinical disease knowledge.


Angst Autologous Bone Marrow Bortezomib Chemotherapy Hematology Lenalidomide Myeloma Plasma cell Staging Thalidomide Therapeutic classification

Editors and affiliations

  • Sagar Lonial
    • 1
  1. 1.Winship Cancer InstituteEmory UniversityAtlantaUSA

Bibliographic information

  • Book Title Myeloma Therapy
  • Book Subtitle Pursuing the Plasma Cell
  • Editors Sagar Lonial
  • Series Title Contemporary Hematology
  • DOI
  • Copyright Information Humana Press 2008
  • Publisher Name Humana Press
  • eBook Packages Medicine Medicine (R0)
  • Hardcover ISBN 978-1-934115-82-4
  • Softcover ISBN 978-1-60327-880-5
  • eBook ISBN 978-1-59745-564-0
  • Edition Number 1
  • Number of Pages XVI, 670
  • Number of Illustrations 0 b/w illustrations, 0 illustrations in colour
  • Topics Hematology
    Internal Medicine
  • Buy this book on publisher's site
Industry Sectors
Health & Hospitals
Oncology & Hematology


From the reviews:

"The book Myeloma Therapy: Pursuing the Plasma Cell, edited by Sagar Lonial, arrives just in time. … a comprehensive, updated review of all the problems concerning myeloma. The authors are among the world’s top scientific leaders in this field … . Consultation and systematic reading are interesting, useful, and very agreeable. It cannot be lacking in the library of the hematologists and oncologists taking care of myeloma patients, and it’s also a worthwhile volume for scientists involved in preclinical research." (Sergio Storti, Laboratory Hematology, Vol. 15 (34), 2009)

“Myeloma therapy by Sagar Lonial deals with various aspects of the plasma cell disorders and multiple myeloma in particular. … this is a goldmine of information written in a style that is accessible to the biochemically interested clinician. … is highly recommended to the advanced reader in this field. It is a reference work on both clinical and biological aspects of multiple myeloma and should be part of the libraries of hospitals for physicians who are professionally frequently involved with the treatment of this disease.” (F. Offner, Acta Clinica Belgica, Vol. 65 (3), 2010)